Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Vijit Chao Phraya 2026 brings a month-long spectacle of light and imagination to Bangkok’s riverfront

Fifth edition expands across 19 riverfront locations plus a floating light installation, with new university collaborations, immersive performances and a night-time tourism programme supporting riverside communities...

DomoAI Launches InkoAI Agent – One Sentence to Ready-to-Post Video

SINGAPORE, Nov. 13, 2026 /PRNewswire/ -- DomoAI, the AI video platform used by more...
Cision PR Newswire

MacKay and Tri-Service General Hospitals Name First Winners of Taiwan’s T+ MedIC Medical Innovation Accelerator

AI-assisted ECG interpretation and a multimodal preventive screening platform take top honors among 14...
Cision PR Newswire

Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026

LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention HONG...
Cision PR Newswire

KUN Group Secures Hong Kong SFC Licence for Type 1, 4 and 9 Activities, Expanding Digital Financial Services

HONG KONG, Nov. 13, 2026 /PRNewswire/ -- A Hong Kong subsidiary of KUN Group...
Cision PR Newswire

Radisson Hotel Group Advances Global Payment Strategy with CellPoint Digital’s Payment Orchestration Platform

DALLAS, Sept. 2, 2025 /PRNewswire/ -- Radisson Hotel Group (RHG), one of the world's largest international hotel groups, has achieved a significant milestone in its...

Bybit Rising Fund Joins Forces with Ceylon Cash to Ready Sri Lankan Youth for Web3-Enabled Economy

DUBAI,...

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

Finloop Unveils Asia’s First Comprehensive Technical Solution for Hong Kong Stock Tokenization

HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Finloop Finance Technology Holding Limited ("Finloop"), a global one-stop Web5 wealth technology platform incubated by Fosun Wealth...

Bybit WSOT 2025 Attracts Quadruple Squads as $8M Main Competition Commences

DUBAI,...

Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study...

- Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion -...
1...2,8842,8852,886...4,527Page 2,885 of 4,527